Reconsider Beta-Blockers for Some Patients Post-MI
June 2024
Recent evidence will reignite debate about the role of beta-blockers post-MI...in patients withOUT heart failure.
Many of us were taught to give a beta-blocker to all post-MI patients as part of the usual “cocktail”...to reduce recurrent CV events.
But this is based on evidence from the 1980s...before routine use of stents, high-intensity statins, dual antiplatelet therapy, etc.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote